[go: up one dir, main page]

WO2012021707A3 - Premature-termination-codons readthrough compounds - Google Patents

Premature-termination-codons readthrough compounds Download PDF

Info

Publication number
WO2012021707A3
WO2012021707A3 PCT/US2011/047421 US2011047421W WO2012021707A3 WO 2012021707 A3 WO2012021707 A3 WO 2012021707A3 US 2011047421 W US2011047421 W US 2011047421W WO 2012021707 A3 WO2012021707 A3 WO 2012021707A3
Authority
WO
WIPO (PCT)
Prior art keywords
codons
premature
termination
readthrough
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2011/047421
Other languages
French (fr)
Other versions
WO2012021707A2 (en
Inventor
Richard A. Gatti
Liutao Du
Robert Damoiseaux
Chih-Hung Lai
Michael Jung
Jin-Mo Ku
Carmen Bertoni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California Berkeley
University of California San Diego UCSD
Original Assignee
University of California Berkeley
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California Berkeley, University of California San Diego UCSD filed Critical University of California Berkeley
Publication of WO2012021707A2 publication Critical patent/WO2012021707A2/en
Publication of WO2012021707A3 publication Critical patent/WO2012021707A3/en
Priority to US13/764,748 priority Critical patent/US9255088B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Radiation-Therapy Devices (AREA)

Abstract

Premature termination codons readthrough compounds, composition thereof, and methods of making and using the same are provided.
PCT/US2011/047421 2010-08-11 2011-08-11 Premature-termination-codons readthrough compounds Ceased WO2012021707A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US13/764,748 US9255088B2 (en) 2010-08-11 2013-02-11 Premature-termination-codons readthrough compounds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37276810P 2010-08-11 2010-08-11
US61/372,768 2010-08-11

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/764,748 Continuation US9255088B2 (en) 2010-08-11 2013-02-11 Premature-termination-codons readthrough compounds

Publications (2)

Publication Number Publication Date
WO2012021707A2 WO2012021707A2 (en) 2012-02-16
WO2012021707A3 true WO2012021707A3 (en) 2012-05-10

Family

ID=45568191

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/047421 Ceased WO2012021707A2 (en) 2010-08-11 2011-08-11 Premature-termination-codons readthrough compounds

Country Status (1)

Country Link
WO (1) WO2012021707A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10077260B2 (en) 2014-01-16 2018-09-18 The Regents Of The University Of California Read-through compound prodrugs suppressing premature nonsense mutations
CN104059060B (en) * 2014-05-30 2017-08-01 西安交通大学 A kind of ketones derivant of 5 (methylene of 1H indoles 3) 1,3 thiazolidine 4 and its synthetic method and application
WO2017049409A1 (en) * 2015-09-25 2017-03-30 The Centre For Drug Research And Development Compositions for promoting readthrough of premature termination codons, and methods of using the same
DK3877376T3 (en) 2018-11-06 2023-10-02 Edgewise Therapeutics Inc Pyridazinone compounds and uses thereof
EP4248972A3 (en) 2018-11-06 2023-12-06 Edgewise Therapeutics, Inc. Pyridazinone compounds and uses thereof
WO2020097258A1 (en) * 2018-11-06 2020-05-14 Edgewise Therapeutics, Inc. Pyridazinone compounds and uses thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030008317A1 (en) * 1999-12-14 2003-01-09 Tularik Inc. Methods of assaying for compounds that inhibit premature translation termination and nonsense-mediated RNA decay
US20090093418A1 (en) * 2006-04-03 2009-04-09 Technion Research & Development Foundation Ltd. Novel aminoglycosides and uses thereof in the treatment of genetic disorders

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030008317A1 (en) * 1999-12-14 2003-01-09 Tularik Inc. Methods of assaying for compounds that inhibit premature translation termination and nonsense-mediated RNA decay
US20090093418A1 (en) * 2006-04-03 2009-04-09 Technion Research & Development Foundation Ltd. Novel aminoglycosides and uses thereof in the treatment of genetic disorders

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LIUTAO DU ET AL.: "Nonaminoglycoside compounds induce read through of nonsense mutations", THE JOURNAL OF EXPERIMENTAL MEDICINE, vol. 206, no. 10, September 2009 (2009-09-01), pages 2285 - 2297 *
LIUTAO DU ET AL.: "Rapid screen for truncating ATM mutations by PTT-ELISA", MUTATION RESEARCH, vol. 640, no. 1-2, 31 January 2008 (2008-01-31), pages 139 - 144, XP022527908, DOI: doi:10.1016/j.mrfmmm.2008.01.002 *

Also Published As

Publication number Publication date
WO2012021707A2 (en) 2012-02-16

Similar Documents

Publication Publication Date Title
IL269858A (en) Pyridone and aza-pyridone compounds, pharmaceutical composition and kits comprising the same and uses thereof
EP3284772B8 (en) Thioethers, methods for their preparation, and compositions including such thioethers
WO2011133504A3 (en) Nanozymes, methods of making nanozymes, and methods of using nanozymes
WO2012003450A3 (en) Biomatrix scaffolds
WO2011084803A3 (en) Coloring agents and methods of use thereof
WO2012087288A3 (en) Metal salt compositions
HK1202549A1 (en) Donepezil pamoate, preparation method and its use
EP2558431A4 (en) Narrow psd hydraulic cement-scm blends, and methods for making same
WO2010118866A8 (en) Trehalulose-containing composition, its preparation and use
EP2245113A4 (en) Phosphorescent compositions, methods of making the compositions, and methods of using the compositions
WO2012024350A3 (en) Anti-cancer adenoviruses
WO2012087327A3 (en) Polymer systems
WO2012075117A3 (en) Small molecule-polymer conjugates and methods of making same
WO2012021707A3 (en) Premature-termination-codons readthrough compounds
WO2010017466A3 (en) Phenobarbital salts; methods of making; and methods of use thereof
WO2010039885A3 (en) Crystalline forms of dexlansoprazole
WO2009143241A3 (en) Differentiation of multi-lineage progenitor cells to pancreatic cells
WO2012051126A3 (en) Anti-inflammatory macrolides
EP2640953A4 (en) Propellant compositions and methods of making and using the same
WO2009151770A3 (en) Colchicine solid-state forms; methods of making; and methods of use thereof
EP2540694A4 (en) Method for producing aryloxy titaniumcomposition, and aryloxytitanium composition
WO2011103413A3 (en) Taxane pro-emulsion formulations and methods making and using the same
WO2012139074A3 (en) Migrastatins and uses thereof
WO2013003547A3 (en) Bhq-conjugates, and related compounds, methods of making the same, and methods of use thereof
WO2010004512A3 (en) Dicarba-analgues of octreotide

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11817039

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11817039

Country of ref document: EP

Kind code of ref document: A2